Market Size of Australia And New Zealand Diabetes Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.14 Billion |
| Market Size (2029) | USD 1.30 Billion |
| CAGR (2024 - 2029) | 2.70 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Australia and New Zealand Diabetes Devices Market Analysis
The Australia And New Zealand Diabetes Devices Market size is estimated at USD 1.14 billion in 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).
- A holistic study of the market studied has been carried out by incorporating various factors, extending from country-specific demographic conditions and business cycles to market-specific microeconomic influences, which were needed to analyze future trends.
- The research uncovers many paradigm shifts in the market studied, in terms of regional competitive advantage and dynamics, primarily to services.
Australia and New Zealand Diabetes Devices Industry Segmentation
Devices are more user-friendly and minimally intrusive, ranging from blood glucose meters and continuous glucose monitoring (CGM) to advanced insulin pumps. The New Zealand diabetes devices market is set to register a CAGR of more than 10% during the forecast period. The Australian and New Zealand diabetes devices market is segmented into management devices (insulin pumps, insulin syringes, insulin cartridges, disposable pens, and jet), monitoring devices (self-monitoring blood glucose and continuous glucose monitoring), and geography (Australia, New Zealand). The report offers the value (in USD million) and volume (in units million) for the above segments. The report will provide a segment-wise breakdown (value and volume) for all the countries covered under the table of contents.
| Monitoring Devices | |||||
| |||||
|
| Management Devices | |||||
| |||||
| Insulin Syringes | |||||
| Insulin Cartridges in Reusable Pens | |||||
| Disposable Pens | |||||
| Jet Injectors |
| Geography | |
| Australia | |
| New Zealand |
Australia And New Zealand Diabetes Devices Market Size Summary
The Australia and New Zealand diabetes devices market is experiencing a steady expansion, driven by an increasing prevalence of diabetes and a growing demand for effective diabetes management solutions. The market is characterized by a diverse range of devices, including blood glucose monitors and continuous glucose monitors (CGMs), which are essential for maintaining optimal blood glucose levels and reducing the risk of diabetes-related complications. The rising awareness of diabetes, particularly type-2 diabetes, has further fueled the demand for these devices. In Australia, government initiatives like the National Diabetes Services Scheme (NDSS) provide subsidized access to blood glucose monitoring products, while in New Zealand, the high out-of-pocket costs for CGMs highlight the significant personal financial burden on diabetic patients. The market is also witnessing technological advancements, with companies like Eli Lilly and Dexcom introducing innovative platforms and systems to enhance diabetes management.
The competitive landscape of the Australia and New Zealand diabetes devices market is highly fragmented, with key players such as Eli Lilly, Sanofi, Novo Nordisk, and Dexcom actively engaging in product launches and technological collaborations to strengthen their market presence. These companies are focusing on developing novel solutions to meet the evolving needs of diabetic patients and to comply with stringent government regulations and WHO recommendations. The introduction of new lancet devices and the increasing adoption of self-monitoring blood glucose meters are expected to contribute to market growth. Despite the challenges posed by high costs and limited medical coverage for certain devices in New Zealand, the market is poised for growth, supported by the ongoing efforts of both public and private sectors to improve diabetes care and management.
Australia And New Zealand Diabetes Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Drivers
-
1.3 Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. Market Segmentation
-
2.1 Monitoring Devices
-
2.1.1 Self-Monitoring Blood Glucose
-
2.1.1.1 Glucometer Devices
-
2.1.1.2 Blood Glucose Test Strips
-
2.1.1.3 Lancets
-
-
2.1.2 Continuous Glucose Monitoring
-
2.1.2.1 Sensors
-
2.1.2.2 Receivers
-
-
-
2.2 Management Devices
-
2.2.1 Insulin Pump
-
2.2.1.1 Insulin Pump Device
-
2.2.1.2 Insulin Pump Reservoir
-
2.2.1.3 Infusion Set
-
-
2.2.2 Insulin Syringes
-
2.2.3 Insulin Cartridges in Reusable Pens
-
2.2.4 Disposable Pens
-
2.2.5 Jet Injectors
-
-
2.3 Geography
-
2.3.1 Australia
-
2.3.2 New Zealand
-
-
Australia And New Zealand Diabetes Devices Market Size FAQs
How big is the Australia And New Zealand Diabetes Devices Market?
The Australia And New Zealand Diabetes Devices Market size is expected to reach USD 1.14 billion in 2024 and grow at a CAGR of 2.70% to reach USD 1.30 billion by 2029.
What is the current Australia And New Zealand Diabetes Devices Market size?
In 2024, the Australia And New Zealand Diabetes Devices Market size is expected to reach USD 1.14 billion.
